This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Genetic Technology Alert. Innovative Method to Prove Accuracy of CRISPR-Cas9 in Human Cells; FDA Approval for an Unique Herpes Simplex Virus Molecular Test; DNA Therapeutic Vaccine for Human Papillomavirus
Genetic Technology Alert. Innovative Method to Prove Accuracy of CRISPR-Cas9 in Human Cells; FDA Approval for an Unique Herpes Simplex Virus Molecular Test; DNA Therapeutic Vaccine for Human Papillomavirus
RELEASE DATE
13-Mar-2015
13-Mar-2015
REGION
Global
Global
Deliverable Type
Technology Alert
Technology Alert
Research Code: D756-00-89-00-00
SKU: HC02702-GL-TA_19596
$250.00
In stock
SKU
HC02702-GL-TA_19596
Description
This issue profiles an innovative method to prove accuracy of CRISPR-Cas9 in human cells, herpes simplex virus molecular test that obtains FDA approval, and DNA therapeutic vaccine for human papillomavirus.
Table of Contents
In This Issue
- 1. INNOVATIVE METHOD TO PROVE ACCURACY OF CRISPR-Cas9 IN HUMAN CELLS
- 2. FDA APPROVAL FOR AN UNIQUE HERPES SIMPLEX VIRUS MOLECULAR TEST
- 3. DNA THERAPEUTIC VACCINE FOR HUMAN PAPILLOMAVIRUS
- 4. RECENT PATENTS IN GENE THERAPY IN KOREA
Popular Topics
This issue profiles an innovative method to prove accuracy of CRISPR-Cas9 in human cells, herpes simplex virus molecular test that obtains FDA approval, and DNA therapeutic vaccine for human papillomavirus.
| Deliverable Types | Technology Alert |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | D756-00-89-00-00 |
| Is Prebook | No |
| Ti Codes | D758 |